Table 10.
Review of publications in which the authors discussed various aspects of drug-eluting balloons (DEBs) in the last five years.
| Authors | Year | Title | Abstract | Ref |
|---|---|---|---|---|
| Borhani et al. | 2018 | Cardiovascular stents: overview, evolution, and next generation. Review | A discussion on different techniques for stent design, mainly based on recent advances in drug-eluting stents. | [2] |
| Bukka et al. | 2018 | Drug-eluting balloon: design, technology and clinical aspects. Topical review | A review and discussion of the evolution, rationale, and comparison of the drug-eluting balloons currently available on the market, with a comparison of different coating techniques. | [14] |
| Naghi et al. | 2016 | New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease | A review summarizes currently available clinical data on the application of drug-coated balloons, followed by a presentation of new paclitaxel drug-coated balloons. | [173] |
| Byrne et al. | 2013 | Drug-coated balloon therapy in coronary and peripheral artery disease Review | A review of the clinical applications of balloons coated with drugs in the treatment of coronary and peripheral artery disease. | [174] |
| Schorn et al. | 2017 | The LUTONIX® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease | A review summarizes the development of the LUTONIX® drug-coated balloon catheter. | [175] |
| Cortesea et al. | 2012 | A comprehensive review of preclinical and clinical data | A review of specific parameters of the paclitaxel-coated balloons for the treatment of coronary artery disease. | [176] |
| Loh et al. | 2012 | Paclitaxel Drug-Coated Balloons A Review of Current Status and Emerging Applications Native Coronary Artery De Novo Lesions | A review of the role of drug-coated balloon DCB in de novo coronary lesions based on clinical evidence. | [177] |
| Katsanos et al. | 2016 | Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials. | A meta-analysis of randomized controlled trials comparing bare-metal stents, paclitaxel-coated balloons, and drug-eluting stents with balloon angioplasty or with each other in the infrapopliteal arteries. | [178] |
| Zhang et al. | 2017 | Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization. | A review and meta-analysis of the current available studies investigating outcomes of drug-eluting balloons and drug-eluting stents in the treatment of infrapopliteal artery disease. | [179] |
| Katsanos et al. | 2014 | Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. | A meta-analysis of randomized controlled trials comparing bare nitinol stents, covered nitinol stents, paclitaxel- or sirolimus-eluting stents, and paclitaxel-coated balloons with plain balloon angioplasty or with each other. | [180] |
| Spiliopoulos et al. | 2019 | Current evidence of drug-elution therapy for infrapopliteal arterial disease. | A review summarizes and discussing data related to the application of infrapopliteal drug-elution devices and their future perspectives. | [181] |
| Chen et al. | 2018 | Drug-delivering endovascular treatment versus angioplasty in artery occlusion diseases: a systematic review and meta-analysis. | A comparison of the efficacy of drug-coated balloons and drug-eluting stents with percutaneous transluminal angioplasty in patients with femoropopliteal or infrapopliteal arterial occlusive disease. | [182] |
| Wua et al. | 2019 | Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease? | A description of the evolution of endovascular therapy for peripheral arterial disease, with highlights regarding the recent debates on the long-term safety of the drug-coated devices for the treatment of this disease. | [32] |
| Caradu et al. | 2019 | Systematic Review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease | A review of the use of drug-coated balloons in the management of femoropopliteal disease and a comparison of this technique with plain old balloon angioplasty. | [183] |
| Yang et al. | 2019 | A meta-analysis of the effects of drug-coated balloons among patients with small-vessel coronary artery disease | Clinical evaluation of drug-coated balloons for patients with small-vessel coronary artery disease. | [184] |
| Li et al. | 2019 | Drug-coated balloon versus drug-eluting stent in de novo small coronary vessel disease A systematic review and meta-analysis | A discussion on the safety and efficacy of the drug-coated balloons and the drug-eluting stents. | [185] |
| Kayssi et al. | 2019 | Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries | A description of the role of drug-eluting technologies, such as drug-eluting balloons, in the management of in-stent restenosis, summarized by the analysis of the efficacy of drug-eluting balloons compared with conventional uncoated balloon angioplasty in people with in-stent restenosis of the femoropopliteal arteries. | [186] |
| Lindquist et al. | 2018 | Drug-Eluting Balloons and Drug-Eluting Stents in the Treatment of Peripheral Vascular Disease | A review of the usage of drug-eluting technologies in the applications addressing the peripheral arterial system. | [187] |
| Mohiaddin et al. | 2018 | Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review | A review of stentless a drug-coated-balloon-only angioplasty in de novo coronary artery disease, comparing more than 40 studies examining the effects of drug-coated-balloon-only percutaneous coronary intervention in a variety of clinical scenarios, including small vessels, bifurcations, calcified lesions, and primary percutaneous coronary intervention. | [188] |
| Liuet al. | 2018 | Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis | A description of the application of drug-eluting stents in the treatment of in-stent restenosis, with the outcome of investigating the death, myocardial infarction, and target-lesion revascularization at longest available follow-up (up to 3 years). | [189] |
| Meneguz-Moreno et al. | 2018 | Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB | A review of applications of drug-coated balloons with the clinical evidence, to enumerate profits, especially in the implementation of bare-metal stents and drug-eluting stents in-stent restenosis. | [190] |
| Kokkinidis et al. | 2018 | Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis | A comparison of second-generation drug-eluting stents and drug-coated balloons for the treatment of coronary artery in-stent restenosis. | [191] |
| Merinopouloset al. | 2018 | Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future? | A review and history of percutaneous coronary intervention and the application of drug-coated balloons, especially within the elderly population. | [192] |